| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emmaus Life Sciences, Inc. (EMMA) has 0 insiders with recent SEC Form 4 filings, including 67 buys and 0 sells. EMMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2019 | Niihara Yutaka | Chairman And CEO | Buy | 8,300 | $2.64 | $21,906.73 | - | |
| Aug 27, 2019 | Lee Willis C | Vice Chairman &COO | Buy | 600 | $2.62 | $1,572.00 | +0.3% | |
| Aug 27, 2019 | Niihara Yutaka | Chairman And CEO | Buy | 31,700 | $2.76 | $87,386.02 | +0.1% | |
| Aug 21, 2019 | Lee Willis C | Vice Chairman &COO | Buy | 1,000 | $3.35 | $3,350.00 | +0.5% | |
| Aug 21, 2019 | Niihara Yutaka | Chairman And CEO | Buy | 19,500 | $3.38 | $65,998.36 | - | |
| May 23, 2019 | Pappajohn John | Director, 10% Owner | Buy | 200,000 | $1.25 | $250,800.00 | +21.8% | |
| Mar 14, 2019 | Pappajohn John | Director, 10% Owner | Buy | 100,000 | $1.68 | $167,600.00 | +12.2% | |
| Jan 5, 2018 | Pappajohn John | Director, 10% Owner | Buy | 10,000 | $3.44 | $34,378.00 | +1.8% | |
| Dec 6, 2017 | Unanue Peter | Director | Buy | 15,000 | $3.65 | $54,735.00 | +125.0% | |
| Dec 6, 2017 | Harris Geoffrey E. | Director | Buy | 4,552 | $3.81 | $17,337.20 | +3.2% |